ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Association of unsweetened and sweetened tea consumption with risk of incident cardiovascular disease: Evidence from the UK Biobank.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of tea consumption, particularly the differences between sweetened and unsweetened tea, on the risk of cardiovascular disease (CVD) remains underexplored. This study investigates the associations between the consumption of unsweetened, sugar-sweetened, and artificially sweetened tea and the incidence of CVD. Methods: We included 177,810 participants from the UK Biobank, with a median follow-up period of 12.7 years. Cox proportional hazards models were utilized to assess the associations between tea intake and the risk of CVD, coronary artery disease (CAD), stroke, and heart failure (HF) incidents. Additionally, we investigated potential interactions with polygenic risk scores (PRS) for CVD. Results: During the follow-up period, 15,003 cases of incident CVD were recorded. A U-shaped association was identified between unsweetened tea consumption and CVD risk, with the lowest risk observed at a consumption level of 0-2 drinks/day (HR: 0.92, 95 % CI: 0.87-0.97). In contrast, no significant associations were found for sugar-sweetened or artificially sweetened tea. The reduced CVD risk associated with unsweetened tea was consistent across various subtypes, including CAD, stroke, and HF. Additionally, no significant interactions were observed between tea consumption and PRS. Conclusions: Consuming unsweetened tea is associated with a reduced risk of incident CVD, CAD, stroke, and HF. In contrast, no significant associations were observed for sugar-sweetened or artificially sweetened tea. These findings indicate that unsweetened tea may contribute positively to the prevention of CVD, independent of genetic risk factors. Further research is needed to validate these results and explore the underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.